1. Home
  2. NCNO vs SRPT Comparison

NCNO vs SRPT Comparison

Compare NCNO & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo nCino Inc.

NCNO

nCino Inc.

HOLD

Current Price

$16.14

Market Cap

2.8B

Sector

Technology

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$17.71

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCNO
SRPT
Founded
2011
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.4B
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
NCNO
SRPT
Price
$16.14
$17.71
Analyst Decision
Buy
Hold
Analyst Count
17
28
Target Price
$33.71
$25.76
AVG Volume (30 Days)
2.4M
2.7M
Earning Date
03-31-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$586,485,000.00
$2,413,715,000.00
Revenue This Year
$11.87
$14.67
Revenue Next Year
$7.87
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.14
47.15
52 Week Low
$15.69
$10.42
52 Week High
$34.55
$111.21

Technical Indicators

Market Signals
Indicator
NCNO
SRPT
Relative Strength Index (RSI) 21.06 36.78
Support Level $15.69 $17.24
Resistance Level $19.06 $18.69
Average True Range (ATR) 1.20 1.13
MACD -0.43 -0.31
Stochastic Oscillator 5.06 12.88

Price Performance

Historical Comparison
NCNO
SRPT

About NCNO nCino Inc.

Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflows and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposits, and other accounts, and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. The company generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: